These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26936939)

  • 1. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease.
    Lambert C; Benjamin P; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Brain; 2016 Apr; 139(Pt 4):1136-51. PubMed ID: 26936939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
    Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
    Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
    Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular Brain Disease Progression and Risk of Stroke: The ARIC Study.
    Koton S; Schneider ALC; Windham BG; Mosley TH; Gottesman RF; Coresh J
    Stroke; 2020 Nov; 51(11):3264-3270. PubMed ID: 32998653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease.
    Duering M; Csanadi E; Gesierich B; Jouvent E; Hervé D; Seiler S; Belaroussi B; Ropele S; Schmidt R; Chabriat H; Dichgans M
    Brain; 2013 Sep; 136(Pt 9):2717-26. PubMed ID: 23864274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of cerebral white matter hyperintensities is related to leucocyte gene expression.
    Jickling GC; Ander BP; Zhan X; Stamova B; Hull H; DeCarli C; Sharp FR
    Brain; 2022 Sep; 145(9):3179-3186. PubMed ID: 35325079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.
    Jokinen H; Koikkalainen J; Laakso HM; Melkas S; Nieminen T; Brander A; Korvenoja A; Rueckert D; Barkhof F; Scheltens P; Schmidt R; Fazekas F; Madureira S; Verdelho A; Wallin A; Wahlund LO; Waldemar G; Chabriat H; Hennerici M; O'Brien J; Inzitari D; Lötjönen J; Pantoni L; Erkinjuntti T
    Stroke; 2020 Jan; 51(1):170-178. PubMed ID: 31699021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients.
    Loos CM; Klarenbeek P; van Oostenbrugge RJ; Staals J
    PLoS One; 2015; 10(9):e0137323. PubMed ID: 26352265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of Brain Parenchymal Damage Related to Cerebral Small Vessel Disease in Carriers of Rare
    Liu ZY; Zhai FF; Liu JY; Zhou YJ; Shu MJ; Huang XH; Han F; Li ML; Zhou LX; Ni J; Yao M; Zhang SY; Cui LY; Jin ZY; Zhu YC
    Neurology; 2023 Nov; 101(20):e1979-e1991. PubMed ID: 37775315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease.
    Jokinen H; Melkas S; Madureira S; Verdelho A; Ferro JM; Fazekas F; Schmidt R; Scheltens P; Barkhof F; Wardlaw JM; Inzitari D; Pantoni L; Erkinjuntti T
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1296-1302. PubMed ID: 27951523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain health index: Towards a combined measure of neurovascular and neurodegenerative structural brain injury.
    Dickie DA; Valdés Hernández MDC; Makin SD; Staals J; Wiseman SJ; Bastin ME; Wardlaw JM
    Int J Stroke; 2018 Oct; 13(8):849-856. PubMed ID: 29672236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial Arterial Dolichoectasia and Stenosis: Risk Factors and Relation to Cerebral Small Vessel Disease.
    Zhai FF; Yan S; Li ML; Han F; Wang Q; Zhou LX; Ni J; Yao M; Zhang SY; Cui LY; Jin ZY; Zhu YC
    Stroke; 2018 May; 49(5):1135-1140. PubMed ID: 29581240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of carotid artery flow parameters with MRI markers of cerebral small vessel disease and patterns of brain atrophy.
    Ellström K; Abul-Kasim K; Siennicki-Lantz A; Elmståhl S
    J Stroke Cerebrovasc Dis; 2023 Mar; 32(3):106981. PubMed ID: 36657270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presumed small vessel disease, imaging and cognition markers in the Alzheimer's Disease Neuroimaging Initiative.
    Fiford CM; Sudre CH; Young AL; Macdougall A; Nicholas J; Manning EN; Malone IB; Walsh P; Goodkin O; Pemberton HG; Barkhof F; Alexander DC; Cardoso MJ; Biessels GJ; Barnes J;
    Brain Commun; 2021; 3(4):fcab226. PubMed ID: 34661106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of location of acute symptomatic vs. 'silent' small vessel lesions.
    Valdés Hernández Mdel C; Maconick LC; Muñoz Maniega S; Wang X; Wiseman S; Armitage PA; Doubal FN; Makin S; Sudlow CL; Dennis MS; Deary IJ; Bastin M; Wardlaw JM
    Int J Stroke; 2015 Oct; 10(7):1044-50. PubMed ID: 26120782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine and brain structure in the elderly: The Rotterdam Study.
    Acarsoy C; Ikram MK; Ikram MA; Vernooij MW; Bos D
    Cephalalgia; 2024 Sep; 44(9):3331024241266951. PubMed ID: 39238475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.
    Soldan A; Wang J; Pettigrew C; Davatzikos C; Erus G; Hohman TJ; Dumitrescu L; Bilgel M; Resnick SM; Rivera-Rivera LA; Langhough R; Johnson SC; Benzinger T; Morris JC; Laws SM; Fripp J; Masters CL; Albert MS
    Brain Commun; 2024; 6(5):fcae276. PubMed ID: 39229494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.